Nakamura M, Ogawa T, Yokono A, Nakamori S, Ohno T, Umezawa K. Synergistic anti-viral effect of oxanosine and ddI against human immunodeficiency virus.
Biomed Pharmacother 2005;
59:47-50. [PMID:
15740935 DOI:
10.1016/j.biopha.2004.05.017]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2004] [Accepted: 05/13/2004] [Indexed: 10/26/2022] Open
Abstract
The combined effect against human immunodeficiency virus (HIV) of oxanosine and 2'3'-dideoxyinosine (ddI) has been evaluated by the production of viral particles, the expression of viral antigens on cell surfaces, and the amount of viral genome integrated in the host cells. Oxanosine alone has no effect on HIV replication up to 100 microg/ml, however, in the presence of ddI, oxanosine revealed concentration dependent inhibition against HIV without cytotoxicity.
Collapse